ResearcherMedical University of LodzActive in the last 2 years

Zuzanna Nowicka

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-7814-5830; OpenAlex author ID A5049799223. Sources: OpenAlex.

Their work

Papers: 3
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 6

Papers, trials and grants by year

2023: 1 paper · 2024: 1 paper · 2025: 1 paper

Papers 3

High FGFR4 protein expression, but not FGFR1 or FGFR2, predicts poor prognosis in pancreatic ductal adenocarcinoma. Co-author DOI 10.1186/s12885-025-14976-2 ↗
53BP1 loss elicits cGAS-STING-dependent antitumor immunity in ovarian and pancreatic cancer. Co-author DOI 10.1038/s41467-024-50999-2 ↗
Metanalyses on metformin's role in pancreatic cancer suffer from severe bias and low data quality - An umbrella review. Co-author DOI 10.1016/j.pan.2023.01.007 ↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Wojciech M Fendler · 2 shared papers, 2023–2024 · strength 0.43
- Paper Metanalyses on metformin's role in pancreatic cancer suffer from severe bias and low data quality - An umbrella review. DOI 10.1016/j.pan.2023.01.007 ↗
- Paper 53BP1 loss elicits cGAS-STING-dependent antitumor immunity in ovarian and pancreatic cancer. DOI 10.1038/s41467-024-50999-2 ↗
Dariusz Grzanka · 1 shared paper, 2025 · strength 0.28
- Paper High FGFR4 protein expression, but not FGFR1 or FGFR2, predicts poor prognosis in pancreatic ductal adenocarcinoma. DOI 10.1186/s12885-025-14976-2 ↗
Marcin Braun · 1 shared paper, 2025 · strength 0.28
- Paper High FGFR4 protein expression, but not FGFR1 or FGFR2, predicts poor prognosis in pancreatic ductal adenocarcinoma. DOI 10.1186/s12885-025-14976-2 ↗
Dipanjan Chowdhury · 1 shared paper, 2024 · strength 0.20
- Paper 53BP1 loss elicits cGAS-STING-dependent antitumor immunity in ovarian and pancreatic cancer. DOI 10.1038/s41467-024-50999-2 ↗
Alexander Spektor · 1 shared paper, 2024 · strength 0.20
- Paper 53BP1 loss elicits cGAS-STING-dependent antitumor immunity in ovarian and pancreatic cancer. DOI 10.1038/s41467-024-50999-2 ↗
Yajie Sun · 1 shared paper, 2024 · strength 0.20
- Paper 53BP1 loss elicits cGAS-STING-dependent antitumor immunity in ovarian and pancreatic cancer. DOI 10.1038/s41467-024-50999-2 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.